Thanks @yu_hung_wang for the shoutout! A product of great collaborative effort @MoffittNews and @VUMChealth Led by our talented trainees Michael Canonico and @hemeparth @VUMCDiscoveries
#Venetoclax plus #hypomethylating agent improves response rates but not survival in #TP53-mutated myelodysplastic syndromesView quoted post on X
Congratulations Somedeb @drsomedeb and team!
doi.org/10.1016/j.bneo…
#MDSsm @BloodPortfolio @Bloodneoplasia @aamdsif @MDSFoundation @ic_MDS